Very interesting news
-
-
I saw that too
I did some digging around, not a lot of new info out there yet but I did find this.
-
A bit more illumination on this dark horse:
The company site
Speculative article at Genomes Unzipped
They're scheduled for a talk at AGBT on Saturday (the shiny new toy session). Rack based set-up, real time tweakability.
Sequence until... Sufficient. I love it!Comment
-
Agbt
Hello - saw your post and thank you. Oxford Nanopore isn't actually on the agenda at this year's AGBT. There are talks through from our academic collaborators about the nanopore research being conducted in their labs, which we hope you will find of interest. Enjoy AGBT!Comment
-
Well huh.
Given the founder of the company is talking and what session it's in I thought there might be something exciting going on... Definitely looking forward to it, anyways.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment